Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 5/2015

01-05-2015 | Retinal Disorders

A new kind of labyrinth-like capillary is responsible for leakage from human choroidal neovascular endothelium, as investigated by high-resolution electron microscopy

Authors: Ulrich Schraermeyer, Sylvie Julien, Antje Biesemeier, Karl Ulrich Bartz-Schmidt, Hartwig Wolburg

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 5/2015

Login to get access

Abstract

Purpose

This study reports the clinicopathologic findings of leaky sites in pathological vessels after submacular removal of choroidal neovascular membranes (CNV). As the site that causes fluid exudation from neovascular vessels is unknown, specific attention was focused on the formation of fenestrations, cellular junctions, and morphologic alteration which can cause endothelial leakage.

Methods

Choroidal neovascular membranes of 15 patients who underwent submacular surgery for CNV were investigated. Five patients received bevacizumab treatment before surgery, and another five received photodynamic therapy before surgery. The remaining five did not receive any other treatment before surgery. All membranes were embedded for transmission electron microscopy. CNVs were analyzed for pathological cell-to-cell connections, fenestrations, or other pathological conditions which can cause leakage of plasma.

Results

The morphology of the newly formed blood channels was very variable, and in principle was not different in treated and untreated patients. The sources of leakage in neovascular choroidal vessels were caused by insufficient endothelial cell connections and by capillaries with microvillar projections into the vessel lumen which blocked cellular perfusion but still allowed the flow of plasma. Fenestrations were only infrequently observed.

Conclusions

A newly discovered type of pathological capillary, called a labyrinth capillary, is very likely responsible for the permanent leakage of fluid. Due to the small vessel lumen, thrombocytes cannot enter these capillaries to close the leakages. Fenestrations did not appear to play a significant role in vascular leakiness.
Appendix
Available only for authorised users
Literature
1.
go back to reference de Juan E Jr, Machemer R (1988) Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol 105:25–29CrossRefPubMed de Juan E Jr, Machemer R (1988) Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol 105:25–29CrossRefPubMed
2.
go back to reference Lambert HM, Capone A Jr, Aaberg TM, Sternberg P Jr, Mandell BA, Lopez PF (1992) Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 113:257–262CrossRefPubMed Lambert HM, Capone A Jr, Aaberg TM, Sternberg P Jr, Mandell BA, Lopez PF (1992) Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 113:257–262CrossRefPubMed
3.
go back to reference Thomas MA, Kaplan HJ (1991) Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome. Am J Ophthalmol 111:1–7CrossRefPubMed Thomas MA, Kaplan HJ (1991) Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome. Am J Ophthalmol 111:1–7CrossRefPubMed
5.
go back to reference Grossniklaus HE, Green WR (1998) Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization. Submacular Surg Trials Res Group Arch Ophthalmol 116:745–749 Grossniklaus HE, Green WR (1998) Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization. Submacular Surg Trials Res Group Arch Ophthalmol 116:745–749
6.
go back to reference Spraul CW, Lang GE, Yoon HS, Grossniklaus HE, Lang GK (1997) Histological characterization and classification of surgically excised choroid neovascular membranes. Klin Monatsbl Augenheilkd 211:324–334. doi:10.1055/s-2008-1035142 CrossRefPubMed Spraul CW, Lang GE, Yoon HS, Grossniklaus HE, Lang GK (1997) Histological characterization and classification of surgically excised choroid neovascular membranes. Klin Monatsbl Augenheilkd 211:324–334. doi:10.​1055/​s-2008-1035142 CrossRefPubMed
7.
go back to reference Spraul CW, Lang GE, Grossniklaus HE, Lang GK (1999) Histologic and morphometric analysis of the choroid, Bruch’s membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol 44(Suppl 1):S10–S32CrossRefPubMed Spraul CW, Lang GE, Grossniklaus HE, Lang GK (1999) Histologic and morphometric analysis of the choroid, Bruch’s membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol 44(Suppl 1):S10–S32CrossRefPubMed
8.
go back to reference Gastaud P, Betis F, Hofman P (2001) Ultrastructural features of peripheral choroidal neovascular membranes in age-related macular degeneration. J Fr Ophtalmol 24:162–168PubMed Gastaud P, Betis F, Hofman P (2001) Ultrastructural features of peripheral choroidal neovascular membranes in age-related macular degeneration. J Fr Ophtalmol 24:162–168PubMed
9.
go back to reference Moshfeghi DM, Kaiser PK, Grossniklaus HE, Sternberg P Jr, Sears JE, Johnson MW, Ratliff N, Branco A, Blumenkranz MS, Lewis H (2003) Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy. Am J Ophthalmol 135:343–350CrossRefPubMed Moshfeghi DM, Kaiser PK, Grossniklaus HE, Sternberg P Jr, Sears JE, Johnson MW, Ratliff N, Branco A, Blumenkranz MS, Lewis H (2003) Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy. Am J Ophthalmol 135:343–350CrossRefPubMed
10.
go back to reference Bressler NM; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials—TAP report 2. Arch Ophthalmol 119:198–207PubMed Bressler NM; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials—TAP report 2. Arch Ophthalmol 119:198–207PubMed
11.
go back to reference Avery RL (2006) Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 26:352–354CrossRefPubMed Avery RL (2006) Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 26:352–354CrossRefPubMed
12.
go back to reference Davidorf FH, Mouser JG, Derick RJ (2006) Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina 26:354–356CrossRefPubMed Davidorf FH, Mouser JG, Derick RJ (2006) Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina 26:354–356CrossRefPubMed
13.
go back to reference Spaide RF, Fisher YL (2006) Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 26:275–278CrossRefPubMed Spaide RF, Fisher YL (2006) Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 26:275–278CrossRefPubMed
14.
go back to reference Tatar O, Yoeruek E, Szurman P, Bartz-Schmidt KU, Tubingen Bevacizumab Study G, Adam A, Shinoda K, Eckardt C, Boeyden V, Claes C, Pertile G, Scharioth GB, Grisanti S (2008) Effect of bevacizumab on inflammation and proliferation in human choroidal neovascularization. Arch Ophthalmol 126:782–790. doi:10.1001/archopht.126.6.782 CrossRefPubMed Tatar O, Yoeruek E, Szurman P, Bartz-Schmidt KU, Tubingen Bevacizumab Study G, Adam A, Shinoda K, Eckardt C, Boeyden V, Claes C, Pertile G, Scharioth GB, Grisanti S (2008) Effect of bevacizumab on inflammation and proliferation in human choroidal neovascularization. Arch Ophthalmol 126:782–790. doi:10.​1001/​archopht.​126.​6.​782 CrossRefPubMed
15.
go back to reference Group CR, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364:1897–1908. doi:10.1056/NEJMoa1102673 CrossRef Group CR, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364:1897–1908. doi:10.​1056/​NEJMoa1102673 CrossRef
16.
go back to reference Krzystolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NA, Li W, Connolly E, O’Neill CA, Miller JW (2002) Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120:338–346CrossRefPubMed Krzystolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NA, Li W, Connolly E, O’Neill CA, Miller JW (2002) Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120:338–346CrossRefPubMed
17.
go back to reference Gibran SK, Sachdev A, Stappler T, Newsome R, Wong D, Hiscott P (2007) Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin). Br J Ophthalmol 91:602–604. doi:10.1136/bjo.2006.108795 CrossRefPubMedCentralPubMed Gibran SK, Sachdev A, Stappler T, Newsome R, Wong D, Hiscott P (2007) Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin). Br J Ophthalmol 91:602–604. doi:10.​1136/​bjo.​2006.​108795 CrossRefPubMedCentralPubMed
18.
go back to reference Vidinova C, Vidinov N (2009) The effect of bevacizumab on the ultrastructure of choroidal neovascular membranes in patients with age-related macular degeneration (AMD). Klin Monatsbl Augenheilkd 226:491–495. doi:10.1055/s-0028-1109429 CrossRefPubMed Vidinova C, Vidinov N (2009) The effect of bevacizumab on the ultrastructure of choroidal neovascular membranes in patients with age-related macular degeneration (AMD). Klin Monatsbl Augenheilkd 226:491–495. doi:10.​1055/​s-0028-1109429 CrossRefPubMed
20.
go back to reference Schouten JS, La Heij EC, Webers CA, Lundqvist IJ, Hendrikse F (2009) A systematic review on the effect of bevacizumab in exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 247:1–11. doi:10.1007/s00417-008-0952-y Schouten JS, La Heij EC, Webers CA, Lundqvist IJ, Hendrikse F (2009) A systematic review on the effect of bevacizumab in exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 247:1–11. doi:10.​1007/​s00417-008-0952-y
21.
go back to reference Kent JS, Iordanous Y, Mao A, Powell AM, Kent SS, Sheidow TG (2012) Comparison of outcomes after switching treatment from intravitreal bevacizumab to ranibizumab in neovascular age-related macular degeneration. Can J Ophthalmol 47:159–164. doi:10.1016/j.jcjo.2012.01.003 CrossRefPubMed Kent JS, Iordanous Y, Mao A, Powell AM, Kent SS, Sheidow TG (2012) Comparison of outcomes after switching treatment from intravitreal bevacizumab to ranibizumab in neovascular age-related macular degeneration. Can J Ophthalmol 47:159–164. doi:10.​1016/​j.​jcjo.​2012.​01.​003 CrossRefPubMed
22.
go back to reference Trabucchi G, Brancato R, De Molfetta V, Verdi M, Pece A, Introini U, Avanza P, Modorati G, Airaghi P (1996) Indocyanine green and fluorescein angiography of surgically excised macular choroidal neovascularizations: correlations with histopathologic and ultrastructural findings. Graefes Arch Clin Exp Ophthalmol 234:294–299CrossRefPubMed Trabucchi G, Brancato R, De Molfetta V, Verdi M, Pece A, Introini U, Avanza P, Modorati G, Airaghi P (1996) Indocyanine green and fluorescein angiography of surgically excised macular choroidal neovascularizations: correlations with histopathologic and ultrastructural findings. Graefes Arch Clin Exp Ophthalmol 234:294–299CrossRefPubMed
23.
25.
go back to reference Hofman P, Blaauwgeers HG, Tolentino MJ, Adamis AP, Nunes Cardozo BJ, Vrensen GF, Schlingemann RO (2000) VEGF-A induced hyperpermeability of blood–retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Curr Eye Res 21:637–645CrossRefPubMed Hofman P, Blaauwgeers HG, Tolentino MJ, Adamis AP, Nunes Cardozo BJ, Vrensen GF, Schlingemann RO (2000) VEGF-A induced hyperpermeability of blood–retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Curr Eye Res 21:637–645CrossRefPubMed
26.
go back to reference Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W (1998) Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 140:947–959CrossRefPubMedCentralPubMed Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W (1998) Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 140:947–959CrossRefPubMedCentralPubMed
27.
28.
go back to reference Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358:1129–1136. doi:10.1056/NEJMoa0707330 CrossRefPubMedCentralPubMed Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358:1129–1136. doi:10.​1056/​NEJMoa0707330 CrossRefPubMedCentralPubMed
29.
go back to reference Peters S, Heiduschka P, Julien S, Ziemssen F, Fietz H, Bartz-Schmidt KU, Schraermeyer U; Tubingen Bevacizumab Study Group (2007) Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol 143:995–1002. doi:10.1016/j.ajo.2007.03.007 Peters S, Heiduschka P, Julien S, Ziemssen F, Fietz H, Bartz-Schmidt KU, Schraermeyer U; Tubingen Bevacizumab Study Group (2007) Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol 143:995–1002. doi:10.​1016/​j.​ajo.​2007.​03.​007
30.
go back to reference Schraermeyer U, Julien S (2012) Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye. Graefes Arch Clin Exp Ophthalmol 250:1303–1313. doi:10.1007/s00417-012-2055-z CrossRefPubMed Schraermeyer U, Julien S (2012) Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye. Graefes Arch Clin Exp Ophthalmol 250:1303–1313. doi:10.​1007/​s00417-012-2055-z CrossRefPubMed
31.
32.
go back to reference Julien S, Biesemeier A, Taubitz T, Schraermeyer U (2014) Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes. Br J Ophthalmol 98(6):813–825. doi:10.1136/bjophthalmol-2013-304019 Julien S, Biesemeier A, Taubitz T, Schraermeyer U (2014) Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes. Br J Ophthalmol 98(6):813–825. doi:10.​1136/​bjophthalmol-2013-304019
33.
go back to reference Julien S, Biesemeier A, Schraermeyer U (2013) In vitro induction of protein complexes between bevacizumab, VEGF-A (1) (6) (5) and heparin: explanation for deposits observed on endothelial veins in monkey eyes. Br J Ophthalmol 97:511–517. doi:10.1136/bjophthalmol-2012-302308 CrossRefPubMed Julien S, Biesemeier A, Schraermeyer U (2013) In vitro induction of protein complexes between bevacizumab, VEGF-A (1) (6) (5) and heparin: explanation for deposits observed on endothelial veins in monkey eyes. Br J Ophthalmol 97:511–517. doi:10.​1136/​bjophthalmol-2012-302308 CrossRefPubMed
Metadata
Title
A new kind of labyrinth-like capillary is responsible for leakage from human choroidal neovascular endothelium, as investigated by high-resolution electron microscopy
Authors
Ulrich Schraermeyer
Sylvie Julien
Antje Biesemeier
Karl Ulrich Bartz-Schmidt
Hartwig Wolburg
Publication date
01-05-2015
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 5/2015
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-014-2733-0

Other articles of this Issue 5/2015

Graefe's Archive for Clinical and Experimental Ophthalmology 5/2015 Go to the issue